帮助非皮肤科医生学习和管理常见皮肤药物不良反应患者的Web应用程序:多中心随机对照试验
Kannattha Chaisriya1, Weeratian Tawanwongsri2, Dichitchai Mettarikanon3
1Informatics Innovation Center of Excellence, School of Informatics, Walailak University, Nakhon Si Thammarat.
Annals of medicine
|October 30, 2024
概括
一个新的网络应用程序显著提高了管理皮肤不良药物反应 (CADRs) 的非皮肤科医生的知识分数. 该工具为初始CADR管理提供了一种有效和令人满意的方法.
科学领域:
- 皮肤病学 皮肤病学
- 医疗教育 医学教育
- 医疗信息学 医疗信息学
背景情况:
- 皮肤的不良药物反应 (CADRs) 对非皮肤科医生来说是一个管理挑战.
- 目前对CADR学习和患者管理的医疗应用有限.
- 需要可访问的工具来支持非专业人员处理CADR.
研究的目的:
- 评估一款新型网络应用程序在增强非皮肤科医生关于CADR管理的知识方面的有效性.
- 为了比较使用应用程序的临床医生与对照组的临床医生所获得的知识.
- 评估用户对CADR教育和管理的Web应用程序的满意度.
主要方法:
- 一个多中心随机对照试验从2023年1月到5月进行.
- 临床医生被随机 (1:1) 分为应用组和对照组.
- 两组之间的知识分数进行了比较,并收集了参与者的反.
主要成果:
- 与对照组 (中位数14.0) 相比,应用组的知识得分明显高 (中位数27.0) (p < 0.001).
- 根据性别,GP地位或CADR患者评估频率,没有观察到知识得分的显著差异.
- 使用网络应用程序的参与者报告了高水平的整体满意度.
结论:
- 网络应用程序是一个有效和方便的工具,非皮肤科医生医生了解和管理CADRs.
- 该应用程序与高用户满意度有关.
- 需要进一步的长期随机对照研究来证实这种工具的持续有效性.
更多相关视频
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.1K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
相关概念视频
Pharmacovigilance
778
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
778
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
